DAVID LIU: Open Payments
NPI 1225050404 · MOHAWK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 42 payments from 14 companies in 2025. Trend: 2023 $1,253 · 2024 $833 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $220 |
| Gilead Sciences, Inc. | 9 | $174 |
| Lilly USA, LLC | 5 | $83 |
| PFIZER INC. | 5 | $82 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| SHIELD THERAPEUTICS INC | 3 | $55 |
| Corcept Therapeutics | 2 | $49 |
| Seqirus USA Inc | 1 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| ABBVIE INC. | 2 | $30 |
Products named: BREZTRI, MOUNJARO, PREVNAR 20, TRELEGY ELLIPTA, ACCRUFER, Korlym, AIRSUPRA, Fluad.
Industry payments across NY — which companies pay providers there.
